Can mindfulness stop psychosis before it starts?
NCT ID NCT06870305
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 5-session group mindfulness program can reduce distress and prevent psychosis in 270 young people (ages 18-30) at ultra-high risk. Participants will either receive the mindfulness training plus usual care, or usual care alone. The goal is to see if mindfulness helps ease symptoms and lowers the risk of a first psychotic episode.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mindfulness-based training for psychosis (MBTP) - a group therapy program
What this could lead to
If it works, this could offer a non-drug way to reduce distress and lower the chance of developing psychosis in young people at high risk.
What could go wrong
This is an early-stage trial with no results yet. The mindfulness program is short (5 sessions over 1 month), and its long-term effects are unknown. It may not prevent psychosis for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire (CHU) de Brest
Brest, 29200, France
Contact
-
Centre Psychothérapique de Nancy
Laxou, 54520, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact